Annual Revenue
$86.69 M
+$63.16 M+268.50%
30 September 2024
Summary:
Tekla Life Sciences Investors annual revenue is currently $86.69 million, with the most recent change of +$63.16 million (+268.50%) on 30 September 2024. During the last 3 years, it has risen by +$21.00 million (+31.96%). HQL annual revenue is now at all-time high.HQL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Tekla Life Sciences Investors quarterly revenue is not available.HQL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Tekla Life Sciences Investors TTM revenue is not available.HQL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HQL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +268.5% | - | - |
| 3 y3 years | +32.0% | - | - |
| 5 y5 years | - | - | - |
HQL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +184.0% | ||||
| 5 y | 5 years | at high | +184.0% | ||||
| alltime | all time | at high | +184.0% |
Tekla Life Sciences Investors Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $86.69 M(+268.5%) | - | - |
| Sept 2023 | $23.52 M(-122.8%) | - | - |
| Sept 2022 | -$103.25 M(-257.2%) | - | - |
| Sept 2021 | $65.69 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.18 M(+65.9%) | $3.49 M(+165.9%) |
| Sept 2019 | - | $1.31 M(>+9900.0%) | $1.31 M(+32.9%) |
| Mar 2019 | - | $0.00(-100.0%) | $988.76 K(0.0%) |
| Sept 2018 | - | $988.76 K | $988.76 K |
FAQ
- What is Tekla Life Sciences Investors annual revenue?
- What is the all time high annual revenue for Tekla Life Sciences Investors?
- What is Tekla Life Sciences Investors annual revenue year-on-year change?
- What is the all time high quarterly revenue for Tekla Life Sciences Investors?
- What is the all time high TTM revenue for Tekla Life Sciences Investors?
What is Tekla Life Sciences Investors annual revenue?
The current annual revenue of HQL is $86.69 M
What is the all time high annual revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high annual revenue is $86.69 M
What is Tekla Life Sciences Investors annual revenue year-on-year change?
Over the past year, HQL annual revenue has changed by +$63.16 M (+268.50%)
What is the all time high quarterly revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly revenue is $2.18 M
What is the all time high TTM revenue for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high TTM revenue is $3.49 M